Views & Analysis Delivering on the promise of creativity Creative approaches should not be stifled as they can boost engagement and the bottom line.
Debates & Insight Sponsored Available on demand: Measuring the cost of the right interve... Available on Demand: Measuring the cost of the right interventions in diabetes.
Debates & Insight Sponsored Available on demand: Cancer Treatment Access: Strategy, Appr... Available on demand: A one-hour live debate on Cancer Treatment Access: Right Strategy, Right Approach, Right Outcomes.
News British pharma, biotech reiterate ‘Remain’ support On the eve of the hugely important referendum, the result is too close to call.
Partner Content Partner Content IMS Health and Reltio Form Alliance to Deploy Advanced Infor... Providing Customers the Best in Big Data Technologies, High-Performance Analytics and Healthcare Information Capabilities
News FDA orders blindness risk warning to GLP-1 agonist labels FDA has ordered all GLP-1 receptor agonist manufacturers to add a warning to their product labels for a rare eye condition that can cause blindness.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
